UA94211C2 - Выделенное полностью человеческое моноклональное cd3 антитело - Google Patents
Выделенное полностью человеческое моноклональное cd3 антителоInfo
- Publication number
- UA94211C2 UA94211C2 UAA200700106A UAA200700106A UA94211C2 UA 94211 C2 UA94211 C2 UA 94211C2 UA A200700106 A UAA200700106 A UA A200700106A UA A200700106 A UAA200700106 A UA A200700106A UA 94211 C2 UA94211 C2 UA 94211C2
- Authority
- UA
- Ukraine
- Prior art keywords
- human monoclonal
- fully human
- antibody
- monoclonal anti
- isolated fully
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Изобретение относится к полностью человеческому моноклональному CD3 антителу или его иммунологически активному фрагменту.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57648304P | 2004-06-03 | 2004-06-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA94211C2 true UA94211C2 (ru) | 2011-04-26 |
Family
ID=38166712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200700106A UA94211C2 (ru) | 2004-06-03 | 2005-06-03 | Выделенное полностью человеческое моноклональное cd3 антитело |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1984931B (ru) |
| UA (1) | UA94211C2 (ru) |
| ZA (1) | ZA200609891B (ru) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT2647707T (lt) * | 2010-11-30 | 2018-11-12 | Chugai Seiyaku Kabushiki Kaisha | Citotoksiškumą indukuojantis terapinis agentas |
| US10358492B2 (en) * | 2012-09-27 | 2019-07-23 | Merus N.V. | Bispecific IgG antibodies as T cell engagers |
| EP3954713A3 (en) * | 2014-03-28 | 2022-03-30 | Xencor, Inc. | Bispecific antibodies that bind to cd38 and cd3 |
| BR112017010793A2 (pt) * | 2014-11-24 | 2017-12-26 | Regeneron Pharma | animal não humano geneticamente modificado, camundongo, métodos para produzir um animal não humano geneticamente modificado e de triagem de candidatos a fármaco direcionados a um antígeno de interesse, e, modelo de camundongo. |
| CN104558180B (zh) * | 2014-12-31 | 2017-11-03 | 四川大学 | 靶向t淋巴细胞的人源单链抗体 |
| EP3247725B1 (en) | 2015-01-23 | 2020-07-01 | Sanofi | Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123 |
| EP3345928B1 (en) * | 2015-07-10 | 2020-06-24 | Merus N.V. | Human cd3 binding antibody |
| EA202090800A1 (ru) * | 2017-09-21 | 2020-08-11 | Уси Байолоджикс Аэлэнд Лимитед | Новые анти-cd3-эпсилон антитела |
| DK3797121T3 (da) * | 2018-05-23 | 2024-07-08 | Pfizer | Antistoffer, der er specifikke for CD3, og anvendelser deraf |
| CN115536740A (zh) * | 2021-06-30 | 2022-12-30 | 苏州方德门达新药开发有限公司 | 介导细胞内有效滞留cd3的空间构象表位及其应用 |
| JP2025509336A (ja) * | 2022-03-09 | 2025-04-11 | アンテンジーン バイオロジクス リミテッド | 新規抗cd3抗体およびその使用 |
| CN115850486B (zh) * | 2022-11-16 | 2023-05-30 | 艾可泰科(浙江)控股有限公司 | 胰岛干细胞在治疗糖尿病中的用途 |
| WO2025050405A1 (zh) * | 2023-09-08 | 2025-03-13 | 成都维瑾柏鳌生物医药科技有限公司 | 一种药物组合物用于制备抗hiv感染的药物的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1169953C (zh) * | 1999-11-30 | 2004-10-06 | 中国医学科学院中国协和医科大学血液学研究所血液病医院 | 抗cd3单克隆抗体重链和轻链可变区基因及其应用 |
| CN1189483C (zh) * | 2001-11-23 | 2005-02-16 | 上海中信国健药业有限公司 | 人源化抗cd3单克隆抗体 |
-
2005
- 2005-06-03 CN CN2005800234997A patent/CN1984931B/zh not_active Expired - Lifetime
- 2005-06-03 UA UAA200700106A patent/UA94211C2/ru unknown
-
2006
- 2006-11-27 ZA ZA200609891A patent/ZA200609891B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200609891B (en) | 2008-07-30 |
| CN1984931B (zh) | 2012-11-28 |
| CN1984931A (zh) | 2007-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003100033A3 (en) | ANTI-αvβ6 ANTIBODIES | |
| IL244803B (en) | Human anti-beta antibodies and their use | |
| TW200639182A (en) | Antibody variants and uses thereof | |
| UA92505C2 (ru) | Композиции на основе антитела против cd3 | |
| IL179672A (en) | Monoclonal antibodies against 3 cd human | |
| NZ605429A (en) | Therapeutic human anti-il-1r1 monoclonal antibody | |
| IL166021A0 (en) | Trabsolant acceptance inducing cells of monocytic origin and their preparation and use | |
| TW200510459A (en) | RG1 antibodies and uses thereof | |
| CY1111622T1 (el) | Ανθρωποποιημενοι ανταγωνιστες anti-cmet | |
| IL168304A (en) | Human monoclonal antibodies against cd25 | |
| WO2010017103A3 (en) | Fully human anti-human nkg2d monoclonal antibodies | |
| IL195338A0 (en) | Optimized fc variants and methods for their generation | |
| NZ594466A (en) | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies | |
| ITMI20031127A1 (it) | Anticorpi anti-hgf-r e loro uso | |
| TW200603828A (en) | Treatment of disorders | |
| UA94211C2 (ru) | Выделенное полностью человеческое моноклональное cd3 антитело | |
| NZ595863A (en) | Antibodies to egfl7 and methods for their use | |
| WO2006029220A3 (en) | Combination therapy with anti-ctla4 and anti-4-1bb antibodies | |
| UA98100C2 (ru) | Гуманизированное моноклональное антитело, которое связывается с человеческим nogo и нейтрализует его | |
| UA96426C2 (ru) | Выделенное человеческое или гуманизированное антитело, которое специфически связывается с il-13 |